CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Financials
Annual revenue, profitability and per-share results for CHARLES RIVER LABORATORIES INTERNATIONAL, INC., as reported in SEC filings.
Revenue · FY2025
$4.02B
▼ 0.9%YoY
Net income · FY2025
-$142.16M
▼ 662.1%YoY
Diluted EPS · FY2025
$-2.91
▼ 1555.0%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS |
|---|---|---|---|---|
| FY2025 | $4.02B | -$142.16M | — | $-2.91 |
| FY2024 | $4.05B | $25.29M | — | $0.20 |
| FY2023 | $4.13B | $480.37M | — | $9.22 |
| FY2022 | $3.98B | $492.61M | — | $9.48 |
Figures as reported in CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Never miss a CRL filing.
Get an email when CRL files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.